Références des travaux et études scientifiques sur l'ostéosarcome

L'ostéosarcome : références scientifiques du site
information sur l'ostéosarcome
Accueil Epidémiologie Classification Stratégie thérapeutique Traitement

Références des travaux et études scientifiques sur l'ostéosarcome :

REFERENCES
1. Ahrens S., Hoffman C, Jabor S. et al (1999). Evaluation of prognostic factors in Tumor volume. Adapted treatment strategy for localized Ewing Sarcoma of bone : the CESS 86 experience. Med. Ped. Oncol. 32 : 186-195.

2. Bacci G, Picci P, Gitelis S et Al (1982). The treatment of localised Ewing's sarcoma : experience at the Istituto Ortopedico Rizzoli in 163 cases treated with and without adjuvant chemotherapy. Cancer, 49 : 1561-1570.

3. Bacci G, Gherlinzoni F, Picci P et al (1986). Adriamycin-methotrexate high dose versus adriamycin-methotrexate moderate dose as adjuvant chemotherapy for osteosarcoma of the extremities : a randomized study. Eur J Cancer Clin Oncol, 22 : 1337-1345.

4. Bacci G., Avella M., Capanna R. et al (1988). Neoadjuvant chemotherapy in the treatment of osteosarcoma of the extremities : preliminary results in 131 cases treated preoperatively with methotrexate and cisdiamminoplatinium. Ital. J. Orthop. Traum., 14 : 23-29.

5. Bacci G, Toni A, Avella M et Al (1989). Long term results in 144 localised Ewing's sarcoma patients treated with combined therapy. Cancer 63 : 1477-1486.

6. Bacci G., Picci P., Rugieri P. et al (1990). Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities. The Rizzoli experience in 127 patients treated preoperatively with methotrexate IV (high versus moderate dose) and cisplatinium IA. Cancer, 65 : 2539-2553.

7. Bacci G., Picci P., Ferrari S. et al (1998). Neoadjuvant chemotherapy for Ewing's sarcoma of bone. Result of two sequential studies. Cancer ; 82 : 1174 – 1183.

8. Bacci G., Ferrari S., Nicole Delépine et al.(1998) Predictive factors of histologic response to primary chemotehrapy in osteosarcoma of the extremity : study of 272 patients preoperatively treated with high dose methotrexate, doxorubicin and cisplatin. J. Clin. Oncol ; 16, 2 : 1-7.

9. Baranzelli MC., Gosselin P., Cazin J.L. et al (1988). Expérience du protocole T10 de Rosen au Centre Oscar Lambret de 1982 à 1985. Ann. Ped. ; 35 : 253-259.

10. Benjamin R.S., Chawla S.P., Carrasco C. et al (1988). Arterial infusion in the treatment of osteosarcoma. In : Ryan JR, Baker O.. Recent concepts in sarcoma treatment. Norwell, MA, Kluwer Academic ; 269-274.

11. Bielack S.S., Bieling P., Erttmann R., Winkler K (1993). Intra-arterial chemotherapy for osteosarcoma : does the result really justify the effort ? In : Bennett Humphrey G. Osteosarcoma adolescents and young adults. Kluwer Academic Publishers. Boston.

12. Bramwell VHC, Burgers M, Sneath R et al (1992). A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults. The first study of the european osteosarcoma intergroup. J. Clin. Oncol. ; 10 : 1579-1591.

13. Brunat-Mentigny M., Demaille MC, Quintana E. et al (1988). La reproduction en France du protocole de Rosen pour les ostéosarcomes. Bull Cancer ; 75 : 201-206.

14. Cortes E.P., Holland J.F., Wang J.J., Glidwell O. (1975). Adriamycin (NSC – 123127) in 87 patients with osteosarcoma. Cancer Chem. Rep. ; 6 : 305.

15. Craft A.W., Burgers J.M.V. (1993). The european osteosarcoma intergroup (EOI) studies 1981-1991. In : Bennett Humphrey G. Osteosarcoma in adolescents and young adults. Boston Kluwer Academic Publisher.

16. Craft A ., Cotteril S., Malcolm A. and al (1998). Ifosfamide- containing chemotherapy in Ewing's sarcoma : the Second United Kingdom Children's Cancer Study Group and the Medical Research Center Study group Ewing's tumor study. J. clin. Oncol. ; 16 : 3628-3633.

17. Gérard Delépine, Goutallier D (1985). La résection dans le traitement des ostéosarcomes des membres. L'amputation conserve-t-elle des indications ? Rev Chir Orthop ; 71 : 451-461.

18. Gérard Delépine, Nicole Delépine (1986) Plaidoyer pour un traitement multidisciplinaire de l'Ewing incluant la chirurgie. Biomedicine and Pharmacotherapy ; 40 : 169-72.

19. Nicole Delépine, Trifaud A., Jasmin C., Favre R., Brun, Gérard Delépine, Tubiana M., Hulin M., Kerbrat P., Dionet C., Lucas P. (1986). Chimiothérapie de l'ostéosarcome par l'association Adriamycine-Cisplatinium pré et post-opératoire. Risques de la chimiothérapie néoadjuvante lorsqu'elle n'est pas suffisamment efficace. Bull. Cancer 73, 288-293.

20. Nicole Delépine, Gérard Delépine, Cornille H. et al (1995). Dose escalation with pharmacokinetics monitoring in methotrexate chemotherapy of osteosarcoma. Anticancer Res. ; 15 : 489-494.

21. Nicole Delépine, Gérard Delépine, Cornille H. et al (1997). Prognostic factors in patients with localized ewing's sarcoma. The effect of actual received drug dose intensity and of histologic response to induction therapy. J.of Chemotherapy ; 9, 5 : 352-363.

22. Nicole Delépine, Gérard Delépine, Bacci G. et al (1996). Influence of Methotrexate dose intensity on outcome of patients with thigh grade osteogenic osteosarcoma. Cancer ; 78 : 2127-2135.

23. Nicole Delépine, Doz F., Gérard Delépine, Lebourgeois J.P., Desbois J.C. (1986) - Intérêt du traitement multidisciplinaire dans le chondrosarcome mésenchymateux de l'enfant (réflexion à propos d'une localisation vertébrale). - Journal Européen de Radiothérapie, 7, 39-41.

24. Gérard Delépine, Goutalier D. (1986) - La biopsie dans les sarcomes des membres et des ceintures. La presse Médicale ; 15 : 1145-1147.

25. Nicole Delépine, Gérard Delépine, Trifaud A., Voicin M.C., Mazabraud A., Jasmin C. (1986). Evaluation of the optimal lengh of the neoadjuvant chemotherapy in osteogenic sarcoma. In : Neoadjuvant chemotherapy, Colloque INSERM, John Libbey Eurotext Ltd, 137, 581-585.

26. Nicole Delépine, Gérard Delépine, Desbois JC, Cornille H., Jasmin C., Astier A., Mathé.G. (1988) - Osteosarcomas : why is T 10's Rosen protocol reproductive or not ? High value of short length of neoadjuvant chemotherapy of methotrexate pharmacokinetics, of salvage chemotherapy by Ifosfamide, Platine, Pirarubicine, for bad responders. - Neoadjuvant chemotherapy Ed Cl Jacquillat, M. Weills, D. Khayat, Colloque Inserm John Libbey, Eurotext Ltd : Vol 169, 529-534.

27. Nicole Delépine, Gérard Delépine, Desbois JC et al (1989). Pharmacokinetics of HDMTX. Conclusion about 622 courses performed in 4 years in children, teenagers and adults. Med & Paed Oncol ; 17(4) : 348.

28. Nicole Delépine, Desbois J.C., Gérard Delépine, Cornille H., Astier A., Alkallaf S. (1989). Individualisation de posologie du Méthotrexate HD par le dosage de concentration plasmatique. Intérêt thérapeutique d'un sarcome ostéogénique. Bull. Cancer ; 76 : 913-918.

29. Gérard Delépine, Nicole Delépine, Desbois J.C. (1990) - Results of multidisciplinary limb salvage in 240 bone sarcomas - Biomedicin and Pharmacotherapy, 44, 217-224.

30. Nicole Delépine, Gérard Delépine, Cornille H., Desbois JC. (1993) - Ewing's sarcoma, multidisciplinary treatment including systematic surgery, results of our EWDD2 pilot study. - Journal of Chemotherapy, Vol 5, Supl 1 : 708-709.

31. Nicole Delépine, Gérard Delépine, Desbois J.C. (1992) - Dose intensité et intensité sérique du Méthotréxate. Intérêt dans le traitement du sarcome ostéogénique. - International Journal of Clinical pharmacy. Pharmacocinétique de la recherche à la clinique. Ed. J. Brès. G. Paris. John Libbey Eurotext. ; 282-289.

32. Desbois JC, Nicole Delépine, Gérard Delépine et Al (1988) . Intérêt d'un nouveau protocole d'induction dans le sarcome d'Ewing à propos de 35 cas. Ann Med Interne ; 139(8) : 534-536.

33. Desbois JC, Nicole Delépine, Gérard Delépine (1991). Ewing's sarcoma. Results of a monocentric study, the EWDD2 protocol. Eur J Cancer ; 165 suppl 2 : 5379.

34. Ennecking W.F., Kagan A. (1975) "Skip" metastases in osteosarcoma. Cancer ; 36 : 2192-2196.

35. Ennecking W.F. (1986) - A system of staging musculoskeletal neoplasms. Clin. Orthop. ; 204 : 9-24.

36. Eriksson AI, Schiller A, Mankin HJ. (1980) The management of chondrosarcoma of bone. Clin. Orthop. ; 153 : 444.

37. Ettinger LJ et al (1981). Adjuvant adriamycin and cis-diamminedichloroplatinum (Cisplatin) in primary osteosarcoma. Cancer ; 47 : 248.

38. Ettinger LJ et al. (1986) Adjuvant adriamycin and cisplatin in newly diagnosed, non metastatic osteosarcoma of the extremity. J. Clin. Oncol. ; 4 : 353.

39. Evans HL, Ayala AG, Romsdahl MM. (1977) Prognostic factors in chondrosarcoma of bone. Cancer ; 40 : 818-831.

40. Ferrari S., Sassoli V., Orladi M. et al (1993). Serum methotrexate concentrations and prognosis in patients with osteosarcoma of the extremities treated with a multidrug neo-adjuvant regimen. J. chemotherapy ; 5, 2 : 135-141.

41. Frei E., Blum R.H., Pitman S.W. et al (1980). High dose methotrexate with Leucovorin rescue. Rationale and spectrum of antitumor activity. Am J. Med. ; 68 : 370-376.

42. Gasparini M, Lombardi F, Gianni C, Fossati-Bellani F. (1981) Localised Ewing Sarcoma : results of integrated therapy and analysis of failures. Eur J Cancer Clin Oncol ; 17 : 1205-9.

43. Gitelis S., Bertoni F., Picci, Campanacci M.. (1981) Chondrosarcoma of bone. J. Bone Joint Surg. ; 63A : 1248.

44. Graft N., Jost W., Keller H.E. et al (1990). Influ? der methotrexat pharmakokinetic und des leucovorin rescues auf die prognose das osteosarkoma. Klin. Pediatr. ; 202 : 340-346.

45. Hayes FA, Thompson EI, Hustu HO et Al (1983) . The response of Ewing's sarcoma to sequential cyclophosphamide and adriamycin induction therapy. J Clin Oncol ; 1 : 45-51.

46. Hayes FA, Thompson EI, Meyer WA et Al (1989). Therapy for localised Ewing's sarcoma of bone. J Clin Oncol ; 7 : 208-13.

47. Jaffe N. (1972) Recent advances in the chemotherapy of metastatic osteogenic sarcoma. Cancer ; 30 : 1627-1631.

48. Jaffe N, Farber S, Traggis D et al (1973). Favourable response of metastatic osteogenic sarcoma to high dose methotrexate with citrovorum rescue and radiation therapy. Cancer ; 31 : 1367-1373.

49. Jaffe N., Traggis D., Salian S., Cassady JR.(1976) Improved out-look for Ewing's sarcoma with combination chemotherapy (vincristine, actinomycin D and cyclophosphamide) and radiation therapy. Cancer ; 38 : 1925.

50. Jaffe N, Frei E III, Traggis D, Watts H. (1977) Weekly high dose methotrexate citrovorum factor in osteogenic sarcoma. Pre-surgical treatment of primary tumor and of overt pulmonary metastases. Cancer ; 39 : 45.

51. Jaffe N ., Frei E., Watts H. et al (1978). High dose methotrexate in osteogenic sarcoma : a 5 year experience. Cancer Treat. Rep. ; 62 : 259.

52. Jaffe N., Goorin A., Link M. et al (1981). High dose methotrexate in osteogenic sarcoma adjuvant chemotherapy and limb salvage results. Cancer Treat. Rep. ; 65 (suppl 1) : 99-106.

53. Jaffe N., Robertson R., Ayala A. et al (1985). Comparison of intra-arterial cis-diaminedichloroplatinum-II with high dose methotrexate and ditrovorum factor rescue in the treatment of primary osteosarcoma. J. Clin. Oncol. ; 3 : 1101-1104.

54. Jaffe N., Raymond AK, Ayala A. et al (1989). Effect of cumulative courses of intra-arterial cis-diamine-dichloroplatinum II on the primary tumor in osteosarcoma. Cancer ; 63 : 63-67.

55. Jurgens H, Exner U, Gadner H et Al (1988). Multidisciplinary treatment of primary Ewing's sarcoma of bone. A 6 year experience off an european cooperative trial. Cancer ; 61 : 23 - 32.

56. Kalifa C., Mlika N., Dubousset J. et al (1988). Expérience du protocole T10 dans le service de pédiatrie de l'Institut Gustave Roussy. Bull Cancer ; 75 : 207-211.

57. Kinsella TJ, Lichter AS, Miser J, Gerber L, Glatstein E.(1984) Local treatment of Ewing's sarcoma : radiation therapy versus surgery. Cancer Treat Rep ; 68 : 695-701.

58. Kreicbergs A., Boquist L., Larsson SE. (1982) Prognostic factors in chondrosarcoma. Cancer ; 50 : 577.

59. Lewis RJ, Marcove RC, Rosen G. (1977) Ewing's sarcoma - functional effects of radiation therapy. J Bone Joint Surg, ; 59 A : 325-32.

60. Link H.P. Goorin A.M., Miser A.W. et al. (1986) The effect of adjuvant chemotherapy in relapse free survival in patients with osteosarcoma of the extremity. N. Engl. J. Med. ; 314 : 1600-1606.

61. Mankin H.J. (1984) . Biopsy of neoplasms of bone and soft tissues : a rational approach. In : Current concept of diagnosis and treatment of bone and soft tissues. Berlin, Heidelberg, Springer Verlag.

62. Mc Kenna RJ, Schwin CP, Soong KY, Higinbotha NL.(1966) Sarcomata of the osteogenic series (osteosarcoma, fibrosarcoma, chondrosarcoma, parostealosteogenic sarcoma and sarcomata arising in abnormal bone). An analysis of 552 cases. J. Bone Joint Surg, ; 48A : 1.

63. Neff JR (1986). Non metastatic ewing's sarcoma of bone, the role of surgical therapy. Clin Orthop Rel Res ; 204 : 111-8.

64. Nesbit ME, Gehan EA, Burgert EO et al (1990). Multimodal therapy for the management of primary non metastatic ewing's sarcoma of bone Along term follow up of the first intergroup study. J. Clin. Oncol. 8 (10) : 1664-74

65. Oberlin O, Habrand JL, Zucker JM et al (1992). No benefit of ifosfamide in Ewing's sarcoma : a non randomized study of the french society of pediatric oncology. J Clin Oncol. ; 10 : 1407-12.

66. Perez CA, Tefft M, Nesbit M et Al (1981). The role of radiation therapy in the management of non metastatic Ewing's sarcoma of bone. Report of the intergroup Ewing's sarcoma study. Int J Radiat Oncol Biol Phys ; 7 : 141-9.

67. Pritchard DJ, Dalhin DC, Dauphine RT et Al (1975). Ewing's sarcoma. A clinico- pathological and statistical analysis of patients surviving five years or longer. J Bone Joint Surg ; 57A : 10-16.

68. Pritchard DJ, Burgert E.O., Unni K.K. (1986). Ewing's sarcoma of bone. Experience with 140 patients. Cancer ; 52 : 2551-2555.

69. Rosen G., Wollner N., Tan C.(1974). Disease free survival in children with Ewing's sarcoma treated with radiation therapy and adjuvant four-drug sequential chemotherapy. Cancer ; 33 : 384-393.

70. Rosen G, Suwansirikal S, Kwon C et al (1974). High dose methotrexate and citrovorum factor rescue and adriamycin in childhood osteogenic sarcoma. Cancer ; 33 : 1151-1163.

71. Rosen G, Murphy ML, Huvos AG et al (1976). Chemotherapy, en bloc resection, and prosthetic bone replacement in the treatment of osteogenic sarcoma.Cancer ; 37:1-11.

72. Rosen G., Huvos A., Mosende C. et al (1978). Chemotherapy and thoracotomy for metastatic osteogenic sarcoma. A model for adjuvant chemotherapy and the rationale for the time of thoracic surgery. Cancer ; 41 : 841-849.

73. Rosen G, Caparros B, Mosende C et Al (1978). Curability of Ewing's sarcoma and considerations for future therapeutic trials. Cancer ; 41 : 888-99.

74. Rosen G., marcove R.C., Capparos B., and coll. (1979). Primary osteogenic sarcoma. The rationale for preoperative chemotherapy and delayed surgery. Cancer, 43, 2163-2177.

75. Rosen G, Caparros B, Nirenberg A et Al (1981). Ewing's sarcoma : ten years experience with adjuvant chemotherapy. Cancer ; 47 : 2204-13.

76. Rosen G., Capparos B., Huvos A.G., (1982). Preoperative chemotherapy for osteogenic sarcoma : selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer, 49, 1221-1230.

77. Rosen G, Niremberg A (1982). Chemotherapy for osteogenic sarcoma : an investigative method, not a recipe. Cancer Treat Rep ; 66 : 1687.

78. Rosen G., Caparros B., Groshen S. et al (1984). Primary osteogenic sarcoma of the femur : a model for the use of preoperative chemotherapy in high risk malignant tumors. Cancer Invest. ; 2 : 181-192.

79. Rosito P, Mancini A, Rondelli R et al (1999). Italian cooperative study for the treatment of children and young adult with localized ewing of bone. Cancer ; 86 : 421-428.

80. Saeter G., Alvegard T.A., Elomaa I. et al (1991). Treatment of osteosarcoma of the extremities with the T 10 protocol, with emphasis on the effect of preoperative chemotherapy with single agent high dose methotrexate : a scandinavian sarcoma group study. J Clin Oncol,; 9 : 1766-1775.

81. Samuels ML, Howe CD. (1967) Cyclophosphamide in the management of Ewing's sarcoma. Cancer ; 20 : 961-966.

82. Sanerkin NG, (1980). The diagnosis and grading of chondrosarcoma of bone. Cancer ; 45 : 582-594.

83. Simon MA et Al (1986). Limb salvage treatment versus amputation for osteosarcoma of the distal end of the femur. J Bone Joint Surg ; 68-A : 1331.

84. Smith M.A., Ungerleider R.S., Horowitz R.S. (1991). Influence of Doxorubicin dose intensity on response and outcome for patients with osteogenic sarcoma and Ewing's sarcoma. J.Nl. Comm. Inst. ; 83 : 1460-1470.

85. Solheim O., Alvegard TA, Elomaa I. (1989) Adjuvant chemotherapy for osteosarcoma. A preliminary report from the scandinavian sarcoma group. Acta. Oncol. ; 28 (suppl 2) : 53-57.

86. Wexler L., Delaney T.F., Tsokos M. et al (1996). Ifosfamide and Etoposide + Vincristine, Doxorubicin and Cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumors. Cancer ; 79 : 901-911.

87. Winkler K., Beron G., Kotz R et al (1984). Neoadjuvant chemotherapy of osteosarcoma : results of a cooperative German/Austrian study. J Clin Oncol ; 2 : 617-624.

88. Winkler K., Beron G., Delling G et al (1988). Neoadjuvant chemotherapy of osteosarcoma : results of a randomized cooperative trial (COSS 82) with salvage chemotherapy based on histological tumor response. J. Clin. Oncol ; 6 : 329-337.

89. Winkler K, Bielack S., Delling G et al (1990). Effect of intra-arterial versus intraveneous cisplatin in addition to systemic doxorubicin, high dose methotrexate and ifosfamide on histologic tumor response in osteosarcoma (study Coss 86). Cancer , 60: 1703-1710.

90. Zucker J.M., Henry-Amar M., Sarrazin D. et al (1983). Intensive systemic chemotherapy in localized Ewing's sarcoma in childhood. Cancer ; 52 : 415-423.

traitement de l'ostéosarcome
Association : malade d'un ostéosarcome | Travaux de Nicole Delépine sur l'ostéosarcome | Ostéosarcome | Traitement de l'ostéosarcome | Etudes | Références